Summit are looking for feedback from caregivers and patients themselves in their commitment to working alongside patients, their families and caregivers in developing utrophin modulators. Utrophin modulators have the potential to be universal treatments for Duchenne muscular dystrophy.
Summit would like your feedback on how well they are doing as a partner of patients, families and caregivers and what they can do to improve.
Please click here to complete a short, anonymous survey.
Your feedback is very important to Summit, and they would like us to pass on their thanks for taking the time to pass on your thoughts.
As always, the best place to hear news about Utrophin modulation from the experts is the Action Duchenne International Conference. Click here for more details.
Sarepta and BioMarin resolve exon skipping patent litigation
